back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-03-27 Tx date 2018-03-15 |
$CMED
CanniMed Therapeutics Inc. |
Aurora Cannabis Inc
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
22,010,117 | ||
| Filed 2018-03-27 Tx date 2018-03-26 |
$CMED
CanniMed Therapeutics Inc. |
Aurora Cannabis Inc
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$94,727,710
+2,202,970 vol $43.00 each |
24,213,087 | |
| Filed 2018-03-26 Tx date 2018-03-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-2,130,940 vol |
0 | |
| Filed 2018-03-26 Tx date 2018-03-24 |
$CMED
CanniMed Therapeutics Inc. |
Bajwa, Gulwant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-80,000 vol |
0 | |
| Filed 2018-03-26 Tx date 2018-03-24 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-91,000 vol |
0 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-78,026,086.80
-2,005,812 vol $38.90 each |
0 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$CMED
CanniMed Therapeutics Inc. |
Knowles, John Lewis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-1,680,909.12
-39,384 vol $42.68 each |
0 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-32,294,507.70
-830,193 vol $38.90 each |
0 | |
| Filed 2018-03-16 Tx date 2018-03-15 |
$CMED
CanniMed Therapeutics Inc. |
GOLDEN OPPORTUNITIES FUND INC.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-156,389,358.80
-4,020,292 vol $38.90 each |
0 | |
| Filed 2018-03-13 Tx date 2018-03-07 |
$CMED
CanniMed Therapeutics Inc. |
Bajwa, Gulwant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$280,950
+60,000 vol $4.68 each |
80,000 | |
| Filed 2018-03-13 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Bajwa, Gulwant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-13 Tx date 2018-03-05 |
$CMED
CanniMed Therapeutics Inc. |
Bajwa, Gulwant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-93,650
-20,000 vol $4.68 each |
60,000 | |
| Filed 2018-03-13 Tx date 2018-03-07 |
$CMED
CanniMed Therapeutics Inc. |
Bajwa, Gulwant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-280,950
-60,000 vol $4.68 each |
0 | |
| Filed 2018-03-13 Tx date 2018-03-05 |
$CMED
CanniMed Therapeutics Inc. |
Bajwa, Gulwant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$93,650
+20,000 vol $4.68 each |
20,000 | |
| Filed 2018-02-28 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-28 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,180 | ||
| Filed 2018-02-28 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-28 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-28 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,588 | ||
| Filed 2018-02-28 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-21 Tx date 2018-02-07 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,440,393.80
-38,000 vol $37.91 each |
2,204,640 | |
| Filed 2018-02-21 Tx date 2018-02-09 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,573,596.63
-73,700 vol $34.92 each |
2,130,940 | |
| Filed 2018-02-21 Tx date 2018-02-09 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,440,393.80
-38,000 vol $37.91 each |
||
| Filed 2018-02-21 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,891,375
-125,000 vol $31.13 each |
||
| Filed 2018-02-21 Tx date 2018-02-07 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,891,375
-125,000 vol $31.13 each |
2,242,640 | |
| Filed 2018-02-20 Tx date 2018-02-16 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,114
+7,200 vol $1.68 each |
18,040 | |
| Filed 2018-02-20 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$187,300
+40,000 vol $4.68 each |
2,367,640 | |
| Filed 2018-02-20 Tx date 2018-02-16 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,114
-7,200 vol $1.68 each |
0 | |
| Filed 2018-02-20 Tx date 2018-02-16 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,967
+5,332 vol $4.68 each |
10,840 | |
| Filed 2018-02-20 Tx date 2018-02-15 |
$CMED
CanniMed Therapeutics Inc. |
Fowler, Allan McLay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-482,000
-50,000 vol $9.64 each |
0 | |
| Filed 2018-02-20 Tx date 2018-02-15 |
$CMED
CanniMed Therapeutics Inc. |
Fowler, Allan McLay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$482,000
+50,000 vol $9.64 each |
50,000 | |
| Filed 2018-02-20 Tx date 2018-02-16 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,971.09
-5,332 vol $1.68 each |
7,200 | |
| Filed 2018-02-12 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
Fowler, Allan McLay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$306,330
+31,777 vol $9.64 each |
31,777 | |
| Filed 2018-02-12 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
Fowler, Allan McLay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-482,000
-50,000 vol $9.64 each |
50,000 | |
| Filed 2018-02-12 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
Fowler, Allan McLay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,010,826.37
-31,777 vol $31.81 each |
0 | |
| Filed 2018-02-12 Tx date 2017-09-07 |
$CMED
CanniMed Therapeutics Inc. |
Fowler, Allan McLay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-09 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,967
+5,332 vol $4.68 each |
8,112 | |
| Filed 2018-02-09 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
Price, Brandon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,114
-7,200 vol $1.68 each |
0 | |
| Filed 2018-02-09 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
Price, Brandon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,967.09
-5,332 vol $4.68 each |
7,200 | |
| Filed 2018-02-09 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
Price, Brandon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,114
+7,200 vol $1.68 each |
32,532 | |
| Filed 2018-02-09 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
Price, Brandon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,967
+5,332 vol $4.68 each |
25,332 | |
| Filed 2018-02-09 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,114
-7,200 vol $1.68 each |
0 | |
| Filed 2018-02-09 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,967.09
-5,332 vol $4.68 each |
7,200 | |
| Filed 2018-02-09 Tx date 2018-02-08 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,114
+7,200 vol $1.68 each |
15,312 | |
| Filed 2018-02-01 Tx date 2018-01-31 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-348,920
-10,000 vol $34.89 each |
91,000 | |
| Filed 2018-01-31 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Holder: Quantico Capital Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-31 Tx date 2018-01-24 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-5,332 vol |
0 | |
| Filed 2018-01-31 Tx date 2018-01-24 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-7,200 vol |
5,332 | |
| Filed 2018-01-31 Tx date 2018-01-24 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,096
+7,200 vol $1.68 each |
10,700 | |
| Filed 2018-01-31 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Holder: Quantico Capital Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-31 Tx date 2018-01-24 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,967
+5,332 vol $4.68 each |
16,032 | |
| Filed 2018-01-25 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-187,300
-40,000 vol $4.68 each |
0 | |
| Filed 2018-01-25 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$187,300
+40,000 vol $4.68 each |
||
| Filed 2018-01-25 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$187,300
+40,000 vol $4.68 each |
||
| Filed 2018-01-25 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+16,736 vol |
923,140 | |
| Filed 2018-01-18 Tx date 2018-01-15 |
$CMED
CanniMed Therapeutics Inc. |
GOLDEN OPPORTUNITIES FUND INC.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+12,532 vol |
4,020,292 | |
| Filed 2018-01-18 Tx date 2018-01-15 |
$CMED
CanniMed Therapeutics Inc. |
Banzet, Douglas
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-12,532 vol |
0 | |
| Filed 2018-01-12 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Duguid, Robert Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-12 Tx date 2018-01-09 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,706
+8,692 vol $2.96 each |
2,005,812 | |
| Filed 2018-01-12 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Duguid, Robert Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-12 Tx date 2018-01-04 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Rob Duguid (Indirect Ownership)
|
Options
51 - Exercise of options
|
-3,840 vol |
0 | |
| Filed 2018-01-12 Tx date 2018-01-04 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Rob Duguid (Indirect Ownership)
|
Options
54 - Exercise of warrants
|
-3,840 vol |
||
| Filed 2018-01-12 Tx date 2018-01-09 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,356
+3,840 vol $2.96 each |
830,193 | |
| Filed 2018-01-09 Tx date 2018-01-04 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-38,302
-6,964 vol $5.50 each |
0 | |
| Filed 2018-01-09 Tx date 2018-01-04 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Rob Duguid (Indirect Ownership)
|
Options
54 - Exercise of warrants
|
-3,840 vol |
0 | |
| Filed 2018-01-09 Tx date 2018-01-09 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$153,208
+27,856 vol $5.50 each |
826,353 | |
| Filed 2018-01-09 Tx date 2018-01-04 |
$CMED
CanniMed Therapeutics Inc. |
Duguid, Robert Michael
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-37,063.39
-12,532 vol $2.96 each |
0 | |
| Filed 2018-01-09 Tx date 2018-01-04 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-86,702
-15,764 vol $5.50 each |
0 | |
| Filed 2018-01-09 Tx date 2018-01-04 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Rob Duguid (Indirect Ownership)
|
Options
51 - Exercise of options
|
$-25,706.59
-8,692 vol $2.96 each |
0 | |
| Filed 2018-01-09 Tx date 2018-01-09 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$346,808
+63,056 vol $5.50 each |
1,997,120 | |
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
-$15,300 vol |
$0 | |
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$2,780 vol $4.60 each |
||
| Filed 2017-12-11 Tx date 2016-12-29 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+2,780 vol |
2,780 | |
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
-$30,300 vol |
$0 | |
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$30,294
+5,508 vol $5.50 each |
5,508 | |
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$30,300 | ||
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
-$92,060 vol |
$0 | |
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$16,736 vol $4.60 each |
||
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$16,736 vol $5.50 each |
||
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
906,404 | ||
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$5,508 vol $4.60 each |
||
| Filed 2017-12-05 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
GOLDEN OPPORTUNITIES FUND INC.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+29,092 vol |
4,007,760 | |
| Filed 2017-12-05 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Banzet, Douglas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
-5,332 vol |
0 | |
| Filed 2017-12-05 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Banzet, Douglas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
-7,200 vol |
5,332 | |
| Filed 2017-12-05 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Banzet, Douglas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+5,332 vol |
12,532 | |
| Filed 2017-12-05 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
Banzet, Douglas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+7,200 vol |
7,200 | |
| Filed 2017-12-05 Tx date 2016-12-29 |
$CMED
CanniMed Therapeutics Inc. |
Banzet, Douglas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-05 Tx date 2017-11-29 |
$CMED
CanniMed Therapeutics Inc. |
GOLDEN OPPORTUNITIES FUND INC.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-29,092 vol |
0 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-273,000
-400,000 vol $0.68 each |
980,000 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
CHING, DONALD
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,967
+5,332 vol $4.68 each |
304,000 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
CHING, DONALD
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,967.09
-5,332 vol $4.68 each |
0 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,114
+7,200 vol $1.68 each |
30,048 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,967
+5,332 vol $4.68 each |
35,380 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$33,650
+20,000 vol $1.68 each |
||
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$33,650
+20,000 vol $1.68 each |
||
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,114
-7,200 vol $1.68 each |
5,332 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,967.09
-5,332 vol $4.68 each |
0 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-33,650
-20,000 vol $1.68 each |
||
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-33,650
-20,000 vol $1.68 each |
||
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$33,650
+20,000 vol $1.68 each |
101,000 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-33,650
-20,000 vol $1.68 each |
0 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Knowles, John Lewis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,114
+7,200 vol $1.68 each |
39,384 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Knowles, John Lewis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,114
-7,200 vol $1.68 each |
120,000 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$273,000
+400,000 vol $0.68 each |
1,370,904 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$497,500
+500,000 vol $0.99 each |
1,870,904 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$67,300
+40,000 vol $1.68 each |
1,910,904 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$673,000
+400,000 vol $1.68 each |
2,310,904 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-497,500
-500,000 vol $0.99 each |
480,000 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-67,300
-40,000 vol $1.68 each |
440,000 | |
| Filed 2017-11-29 Tx date 2017-11-24 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-673,000
-400,000 vol $1.68 each |
40,000 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-273,000
-400,000 vol $0.68 each |
||
| Filed 2017-10-24 Tx date 2017-09-08 |
$CMED
CanniMed Therapeutics Inc. |
Harkness, Howard Glenn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$771,200
+80,000 vol $9.64 each |
80,000 | |
| Filed 2017-10-24 Tx date 2017-06-08 |
$CMED
CanniMed Therapeutics Inc. |
Harkness, Howard Glenn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-05 Tx date 2017-10-03 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-51,250
-5,000 vol $10.25 each |
81,000 | |
| Filed 2017-09-27 Tx date 2017-09-07 |
$CMED
CanniMed Therapeutics Inc. |
Fowler, Allan McLay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-27 Tx date 2017-09-08 |
$CMED
CanniMed Therapeutics Inc. |
Fowler, Allan McLay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$964,000
+100,000 vol $9.64 each |
100,000 | |
| Filed 2017-09-19 Tx date 2017-09-18 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,898
-200 vol $9.49 each |
90,600 | |
| Filed 2017-09-19 Tx date 2017-09-18 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,411
-1,000 vol $9.41 each |
86,000 | |
| Filed 2017-09-19 Tx date 2017-09-18 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-34,070.40
-3,600 vol $9.46 each |
87,000 | |
| Filed 2017-09-19 Tx date 2017-09-18 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,899
-200 vol $9.49 each |
90,800 | |
| Filed 2017-08-16 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Rob Duguid (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,840 | ||
| Filed 2017-08-16 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
6,964 | ||
| Filed 2017-08-16 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-16 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Rob Duguid (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-01 Tx date 2017-07-31 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,022
-200 vol $10.11 each |
99,800 | |
| Filed 2017-08-01 Tx date 2017-07-31 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,005
-100 vol $10.05 each |
91,000 | |
| Filed 2017-08-01 Tx date 2017-07-31 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,042
-600 vol $10.07 each |
91,100 | |
| Filed 2017-08-01 Tx date 2017-07-31 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,040
-500 vol $10.08 each |
91,700 | |
| Filed 2017-08-01 Tx date 2017-07-31 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,024.90
-300 vol $10.08 each |
92,200 | |
| Filed 2017-08-01 Tx date 2017-07-31 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-72,180
-7,200 vol $10.03 each |
92,500 | |
| Filed 2017-08-01 Tx date 2017-07-31 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,005
-100 vol $10.05 each |
99,700 | |
| Filed 2017-07-20 Tx date 2017-07-18 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$68,250
+100,000 vol $0.68 each |
100,000 | |
| Filed 2017-07-20 Tx date 2017-07-18 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-68,250
-100,000 vol $0.68 each |
20,000 | |
| Filed 2017-07-20 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-18 Tx date 2017-07-13 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,056,869
+126,500 vol $8.35 each |
1,934,064 | |
| Filed 2017-07-13 Tx date 2017-01-30 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
-$306,400 vol $5.50 each |
$0 | |
| Filed 2017-07-13 Tx date 2017-01-30 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
-$693,600 vol $5.50 each |
$0 | |
| Filed 2017-07-13 Tx date 2017-07-07 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$175,070
+21,500 vol $8.14 each |
||
| Filed 2017-07-13 Tx date 2017-07-07 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$175,070
+21,500 vol $8.14 each |
||
| Filed 2017-07-13 Tx date 2017-01-30 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$693,594
+126,108 vol $5.50 each |
1,807,564 | |
| Filed 2017-07-13 Tx date 2017-01-30 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$306,399
+55,709 vol $5.50 each |
798,497 | |
| Filed 2017-06-30 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$57,600
+7,200 vol $8.00 each |
963,604 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
970,904 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
||
| Filed 2017-06-30 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
||
| Filed 2017-06-29 Tx date 2017-06-28 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
963,704 | |
| Filed 2017-06-29 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,312
+7,300 vol $7.99 each |
||
| Filed 2017-06-28 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,800
+3,600 vol $8.00 each |
||
| Filed 2017-06-28 Tx date 2017-06-27 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,800
+3,600 vol $8.00 each |
||
| Filed 2017-06-16 Tx date 2017-06-15 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$395,500
+50,000 vol $7.91 each |
956,404 | |
| Filed 2017-02-02 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$16,736 vol $5.50 each |
||
| Filed 2017-02-02 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$16,736 vol $4.60 each |
$108,796 | |
| Filed 2017-02-02 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$2,780 vol $4.60 each |
$18,080 | |
| Filed 2017-02-02 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$5,508 vol $4.60 each |
$35,808 | |
| Filed 2017-01-11 Tx date 2017-01-05 |
$CMED
CanniMed Therapeutics Inc. |
GOLDEN OPPORTUNITIES FUND INC.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$1,619,970
+294,540 vol $5.50 each |
3,978,668 | |
| Filed 2017-01-11 Tx date 2017-01-05 |
$CMED
CanniMed Therapeutics Inc. |
GOLDEN OPPORTUNITIES FUND INC.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
-$1,620,000 vol |
$0 | |
| Filed 2016-12-30 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-30 Tx date 2016-12-29 |
$CMED
CanniMed Therapeutics Inc. |
GOLDEN OPPORTUNITIES FUND INC.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
29,092 | ||
| Filed 2016-12-30 Tx date 2016-12-29 |
$CMED
CanniMed Therapeutics Inc. |
GOLDEN OPPORTUNITIES FUND INC.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$1,620,000 | ||
| Filed 2016-12-30 Tx date 2016-12-29 |
$CMED
CanniMed Therapeutics Inc. |
Banzet, Douglas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,532 | ||
| Filed 2016-12-30 Tx date 2016-12-29 |
$CMED
CanniMed Therapeutics Inc. |
GOLDEN OPPORTUNITIES FUND INC.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,684,128 | ||
| Filed 2016-12-30 Tx date 2016-12-29 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,000
+3,500 vol $12.00 each |
3,500 | |
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,681,456 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Price, Brandon
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,532 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Price, Brandon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,532 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$15,300 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
mackler, Bruce
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,588 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,532 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Holder: Quantico Capital Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
608,000 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,532 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$30,300 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,180 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Holbrook, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
120,000 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,532 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Greer, Marianne
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
22,848 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
CHING, DONALD
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
5,332 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
CHING, DONALD
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
298,668 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Bajwa, Gulwant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
80,000 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
6,964 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Rob Duguid (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,840 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$306,400 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
Lashyn, Dwayne Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
APEX INVESTMENT LIMITED PARTNERSHIP
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
742,788 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,380,000 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$92,060 | ||
| Filed 2016-12-29 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Zettl, Brenton Harold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
906,404 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
15,764 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Rob Duguid (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
8,692 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
$693,600 | ||
| Filed 2016-12-29 Tx date 2016-12-21 |
$CMED
CanniMed Therapeutics Inc. |
SASKWORKS VENTURE FUND INC.
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|